Milestone Pharmaceuticals Inc. (MIST)

Milestone Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	45.09	25.31	13.76	7.64	114.14	72.31
Short-Term Investments	10.87	44.38	52.24	56.95	-	70
Cash & Short-Term Investments	55.96	69.7	66	64.59	114.14	142.31
Cash Growth	-37.46%	5.59%	2.20%	-43.42%	-19.79%	18.77%
Other Receivables	1.49	1.72	1.45	1.21	0.48	0.95
Receivables	1.49	1.72	1.45	1.21	0.48	0.95
Prepaid Expenses	2.36	1.84	3.18	6.01	4.3	5.43
Other Current Assets	0.67	0.67	2.4	-	-	-
Total Current Assets	60.48	73.93	73.03	71.8	118.92	148.69
Property, Plant & Equipment	1.41	1.57	2.19	2.68	0.93	1.29
Total Assets	61.89	75.5	75.23	74.48	119.85	149.97
Accounts Payable	2.38	1.93	3.98	2.26	4.38	4.64
Accrued Expenses	10.04	5.62	2.7	3.38	2.17	1.27
Current Portion of Leases	0.54	0.57	0.55	0.5	0.22	0.25
Total Current Liabilities	12.96	8.13	7.23	6.14	6.78	6.16
Long-Term Debt	54.29	53.35	49.77	-	-	-
Long-Term Leases	0.76	0.87	1.46	2	0.47	0.7
Total Liabilities	68.01	62.35	58.46	8.14	7.25	6.86
Common Stock	288.19	288.05	260.5	273.9	251.9	251.68
Additional Paid-In Capital	40.92	39.57	33.83	24.44	15.71	8.53
Retained Earnings	-388.31	-367.55	-326.03	-266.34	-207.95	-163.47
Comprehensive Income & Other	53.08	53.08	48.46	34.35	52.94	46.37
Total Common Equity	-6.12	13.15	16.77	66.35	112.6	143.12
Shareholders' Equity	-6.12	13.15	16.77	66.35	112.6	143.12
Total Liabilities & Equity	61.89	75.5	75.23	74.48	119.85	149.97
Total Debt	55.59	54.8	51.78	2.49	0.7	0.94
Net Cash (Debt)	0.37	14.9	14.23	62.09	113.44	141.37
Net Cash Growth	-99.00%	4.71%	-77.09%	-45.26%	-19.75%	18.50%
Net Cash Per Share	0.01	0.24	0.33	1.46	2.71	4.82
Filing Date Shares Outstanding	66.37	66.26	43.06	42.8	42.23	41.25
Total Common Shares Outstanding	66.37	66.26	43.06	42.8	42.23	41.25
Working Capital	47.51	65.8	65.81	65.66	112.15	142.53
Book Value Per Share	-0.09	0.20	0.39	1.55	2.67	3.47
Tangible Book Value	-6.12	13.15	16.77	66.35	112.6	143.12
Tangible Book Value Per Share	-0.09	0.20	0.39	1.55	2.67	3.47
Machinery	-	0.4	0.38	0.28	0.43	0.43
Leasehold Improvements	-	0.09	0.09	0.1	0.03	0.03

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q